New

Trackinsight is part of ETF One, the fully integrated ETF platform of Kepler Cheuvreux. Learn more →

Help us improve your experience. Please confirm your investor type:

Compare ETFs Easily

The Ultimate ETF Comparison Tool - Try Now!

Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.

Sponsored Content
In association with
Janus Henderson

Trump’s Pharma tariff threat: Analysing the implications for European CLOs

Healthcare is the largest sector within the Collateralised Loan Obligation (CLO) universe. Portfolio manager Denis Struc and David Huang explore how to navigate this environment for CLO investors.

JH CLO Healthcare
Janus Henderson Logo

By Janus Henderson Investors
September 11, 2025

Trackinsight Newsletter
Get What 30,000+ ETF Investors Already Know
Your newsletter subscriptions with us are subject to Trackinsight’s Privacy Policy and Terms and Conditions.

Last week, US President Trump announced a sweeping investigation into possible tariffs on pharmaceuticals – a sector that, until now, had largely escaped the trade measures levied on automobiles, copper, and other industries. The duties under consideration, pencilled to take effect in 12 to 18 months, would apply across the entire drug-development chain, from active ingredients to finished products and, in characteristically hyperbolic fashion, could be set as high as 200%.

Trackinsight Services

ETF Data Built for Precision

Trackinsight delivers reliable and comprehensive coverage on 13,000+ ETFs

Start your free trial
Continue reading on Janus Henderson Investors â†’
This article was originally published by Janus Henderson Investors on 7/21/2025. View the original post here
Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight